Bened Life is releasing the first gut-brain medical probiotic, Neuralli™, on Wednesday, August 3, 2022. Made in the United States and utilizing the patented probiotic strain L. plantarum PS128, Neuralli is designed to promote mental health and support neurological conditions including but not limited to Parkinson’s disease (PD) and autism spectrum disorder (ASD).

The unique gut-brain axis probiotic strain L. plantarum PS128 is backed by 11 clinical studies and addresses the specific dietary needs of people living with neurological conditions. Neuralli has been shown to help balance serotonin, dopamine, cortisol, and other molecules that affect mood, mind, and movement, while also helping regulate gastrointestinal tract health.

A medical probiotic, a type of medical food, is defined as "a food which is formulated to be consumed or administered enterally under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation.” PS128 has been shown to influence the production and metabolism of serotonin and dopamine by gut cells – levels of one or both of these neurotransmitters are dysregulated in neurodevelopmental conditions such as ASD. Neuralli's classification as a medical probiotic is based upon results from three clinical studies of PS128 in autistic children that noted a neurological health benefit. No naturally occurring food has proven to show the same results.

Many people with neurological conditions experience chronic gastrointestinal discomfort including constipation and cramping, disordered sleeping, increased anxiety, and depression. Neuralli empowers the gut microbiome to balance the health of both gut and brain via the gut-brain axis by:

"Bened Life is dedicated to helping those with mental health and neurological conditions, whether that’s Parkinson’s disease, autism spectrum disorder, anxiety, depression, or insomnia, live their life to their full potential. With 60 billion colony forming units (CFUs) per two-capsule serving, Neuralli is poised to lead the gut-brain medical probiotic category. It’s an honor to be leading Bened Life as medical probiotics become more mainstream,” says Franklin Cheng, CEO of Bened Life. “Neuralli is the culmination of our dedication to the research and development of psychobiotics, and is the first product launch since the merger of Bened Biomedical and Oryx Biomedical. I look forward to what’s next for Bened Life.”

Neuralli works best with consistent use, and each capsule is acid-resistant, vegan and free of common allergens such as gluten, nuts, and dairy. Ingredients are L. plantarum PS128, inulin, microcrystalline cellulose, silicon dioxide, magnesium stearate, and vegetable capsule (hydroxypropyl methylcellulose and water).

For more information, please visit BenedLife.com.

Share article on social media or email:

Questions about a news article you've read?

Reach out to the author: contact and available social following information is listed in the top-right of all news releases.

Questions about your PRWeb account or interested in learning more about our news services?

Call PRWeb:1-866-640-6397

©Copyright 1997-2015, Vocus PRW Holdings, LLC. Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.